📊 MDCE Key Takeaways
Is MDCE a Good Investment? Thesis Analysis
Medical Care Technologies Inc. exhibits severe financial distress with negative stockholders' equity of -$228.5K, indicating the company is technically insolvent. The company is hemorrhaging cash with negative operating cash flow of -$895.6K and negative free cash flow of -$901.8K, while maintaining minimal liquidity (current ratio of 0.16x) and essentially no cash reserves ($742). With no revenue data available, persistent operating losses of -$6.7M, and zero insider buying activity, the company appears to be in terminal decline.
Why Buy MDCE? Key Strengths
- Minimal capital expenditure requirements ($6.2K) suggest low operational overhead
- Business Services sector provides potential for lean operations
- Small asset base ($1.2M) limits downside impact from liquidation
MDCE Investment Risks to Consider
- Negative stockholders' equity represents insolvency and extinction risk
- Severe liquidity crisis with current ratio of 0.16x - unable to meet short-term obligations
- Negative operating cash flow of -$895.6K indicates unsustainable burn rate
- No revenue visibility - fundamental business model viability unknown
- Total liabilities exceed total assets by $200K despite minimal balance sheet
- Data freshness from 2012 suggests potential delisting or dormant status
- ROA of -586.3% demonstrates catastrophic asset productivity
Key Metrics to Watch
- Cash depletion timeline at current burn rate
- Any revenue generation or return to positive operating cash flow
- Stockholders' equity recovery or bankruptcy filing
- Updated SEC filings to confirm company status
MDCE Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
MDCE Profitability Ratios
MDCE vs Default Sector
How Medical Care Technologies Inc. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is MDCE Overvalued or Undervalued?
Based on fundamental analysis, Medical Care Technologies Inc. has mixed fundamental signals relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
MDCE Balance Sheet & Liquidity
MDCE 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: Medical Care Technologies Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline.
MDCE Growth Metrics (YoY)
MDCE Capital Allocation
MDCE SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Medical Care Technologies Inc. (CIK: 0001404593)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MDCE
What is the AI rating for MDCE?
Medical Care Technologies Inc. (MDCE) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are MDCE's key strengths?
Claude: Minimal capital expenditure requirements ($6.2K) suggest low operational overhead. Business Services sector provides potential for lean operations.
What are the risks of investing in MDCE?
Claude: Negative stockholders' equity represents insolvency and extinction risk. Severe liquidity crisis with current ratio of 0.16x - unable to meet short-term obligations.
What is MDCE's revenue and growth?
Medical Care Technologies Inc. reported revenue of N/A.
Does MDCE pay dividends?
Medical Care Technologies Inc. does not currently pay dividends.
Where can I find MDCE SEC filings?
Official SEC filings for Medical Care Technologies Inc. (CIK: 0001404593) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MDCE's EPS?
Medical Care Technologies Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MDCE a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Medical Care Technologies Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is MDCE stock overvalued or undervalued?
Valuation metrics for MDCE: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy MDCE stock in 2026?
Our dual AI analysis gives Medical Care Technologies Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MDCE's free cash flow?
Medical Care Technologies Inc.'s operating cash flow is $-895.6K, with capital expenditures of $6.2K.
How does MDCE compare to other Default stocks?
Vs Default sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 0.16 (avg: 1.8).